HUMAN RNA POLYMERASE II TRANSCRIPTION PAST PAH ADDUCTS

人类 RNA 聚合酶 II 转录 PAH 加合物

基本信息

  • 批准号:
    6167227
  • 负责人:
  • 金额:
    $ 25.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-30 至 2003-09-29
  • 项目状态:
    已结题

项目摘要

In this new application, Dr. Scicchitano proposes to elucidate mechanisms by which covalently modified bases in DNA cause human RNA polymerase II to stall at the altered site, or allow it to progress past the lesion, resulting in the formation of full-length transcripts. It is surmised that stalling of RNA polymerase II at polycyclic aromatic hydrocarbon (PAH) adducts present in transcribed DNA is not merely a function of presence of the lesion in the template, but is related to the three-dimensional orientation of the adduct and the base incorporated into the transcript at the damaged site. The following aims are proposed to address these ideas: 1) Templates suitable for transcription by RNA polymerase II present in nuclear extracts will be prepared. They will contain the CMV immediate early promoter/enhancer element, a G-less cassette, and a site-specific stereochemically pure PAH adduct. 2) The templates will be used in transcription run-off assays to assess potential blocks to RNA synthesis and relative amounts of bypass. 3) The base sequence of full-length transcripts obtained by elongation past the modified base in DNA will be determined; this will test for nucleotide incorporation at or near the adduct. 4) The base sequence at the 3' ends of truncated transcripts will be characterized. Truncated transcripts often form as a result of RNA polymerase stalling due to the presence of a lesion. Finally, (5) transcription past site-specific PAH lesions will be studied using extracts from cells derived from patients with Cockayne's syndrome, a disease characterized by the inability to carry out rapid repair of DNA adducts present in expressed genes. The data will be interpreted in light of information concerning the mutagenicity, tumorigenicity, repair, and structural features of the DNA adducts being studied. They will also help to gain a better understanding of the role of transcription as a biological endpoint adversely affected by these highly carcinogenic agents.
在这个新的应用中,Scicchitano博士建议阐明机制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David A Scicchitano其他文献

David A Scicchitano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David A Scicchitano', 18)}}的其他基金

RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    6778625
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
HUMAN RNA POLYMERASE II TRANSCRIPTION PAST PAH ADDUCTS
人类 RNA 聚合酶 II 转录 PAH 加合物
  • 批准号:
    6525247
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7082047
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7470187
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    8369308
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    8002023
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7254181
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
HUMAN RNA POLYMERASE II TRANSCRIPTION PAST PAH ADDUCTS
人类 RNA 聚合酶 II 转录 PAH 加合物
  • 批准号:
    6382376
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    6916582
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7784041
  • 财政年份:
    2000
  • 资助金额:
    $ 25.49万
  • 项目类别:

相似海外基金

Dissecting the regulatory role of a eukaryotic transcription factor in RNA-templated transcription catalyzed by DNA-directed RNA polymerase II
剖析真核转录因子在 DNA 指导的 RNA 聚合酶 II 催化的 RNA 模板转录中的调节作用
  • 批准号:
    10047065
  • 财政年份:
    2020
  • 资助金额:
    $ 25.49万
  • 项目类别:
The roles of TFIIB and TFIIF in transcription by DNA-directed RNA Polymerase II
TFIIB 和 TFIIF 在 DNA 指导的 RNA 聚合酶 II 转录中的作用
  • 批准号:
    8911579
  • 财政年份:
    2015
  • 资助金额:
    $ 25.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了